82 related articles for article (PubMed ID: 17126795)
1. [The PAI-1 swing: microenvironment and cancer cell migration].
Malo M; Charrière-Bertrand C; Chettaoui C; Fabre-Guillevin E; Maquerlot F; Lackmy A; Vallée B; Delaplace F; Barlovatz-Meimon G
C R Biol; 2006 Dec; 329(12):919-27. PubMed ID: 17126795
[TBL] [Abstract][Full Text] [Related]
2. [Role of PAI-1 plasminogen activator inhibitor in tumor invasion and angiogenesis].
Bajou K
Bull Mem Acad R Med Belg; 2002; 157(5-6):313-8. PubMed ID: 12557575
[TBL] [Abstract][Full Text] [Related]
3. Regulation of programmed cell death by plasminogen activator inhibitor type 1 (PAI-1).
Lademann UA; Rømer MU
Thromb Haemost; 2008 Dec; 100(6):1041-6. PubMed ID: 19132228
[TBL] [Abstract][Full Text] [Related]
4. [Regulation of PAI-1 expression].
Wyrzykowska P; Kasza A
Postepy Biochem; 2009; 55(1):46-53. PubMed ID: 19514465
[TBL] [Abstract][Full Text] [Related]
5. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
[TBL] [Abstract][Full Text] [Related]
6. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
7. Expression of plasminogen activator inhibitors type 1 and type 3 and urokinase plasminogen activator protein and mRNA in breast cancer.
Castelló R; Landete JM; España F; Vázquez C; Fuster C; Almenar SM; Ramón LA; Radtke KP; Estellés A
Thromb Res; 2007; 120(5):753-62. PubMed ID: 17258797
[TBL] [Abstract][Full Text] [Related]
8. Cell motility. Making connections count.
Lauffenburger DA
Nature; 1996 Oct; 383(6599):390-1. PubMed ID: 8837766
[No Abstract] [Full Text] [Related]
9. PAI-1 and cellular migration: dabbling in paradox.
Vaughan DE
Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1522-3. PubMed ID: 12377726
[No Abstract] [Full Text] [Related]
10. Plasminogen activator inhibitor type 1 inhibits smooth muscle cell proliferation in pulmonary arterial hypertension.
Kouri FM; Queisser MA; Königshoff M; Chrobak I; Preissner KT; Seeger W; Eickelberg O
Int J Biochem Cell Biol; 2008; 40(9):1872-82. PubMed ID: 18337154
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of PAI-1 expression in breast cancer carcinoma cells by siRNA at nanomolar range.
Meryet-Figuières M; Resina S; Lavigne C; Barlovatz-Meimon G; Lebleu B; Thierry AR
Biochimie; 2007 Oct; 89(10):1228-33. PubMed ID: 17509745
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of TGF-beta1-induced intimal growth: plasminogen-independent activities of plasminogen activator inhibitor-1 and heterogeneous origin of intimal cells.
Otsuka G; Stempien-Otero A; Frutkin AD; Dichek DA
Circ Res; 2007 May; 100(9):1300-7. PubMed ID: 17431190
[TBL] [Abstract][Full Text] [Related]
13. Improved autograft survival of mesenchymal stromal cells by plasminogen activator inhibitor 1 inhibition.
Copland IB; Lord-Dufour S; Cuerquis J; Coutu DL; Annabi B; Wang E; Galipeau J
Stem Cells; 2009 Feb; 27(2):467-77. PubMed ID: 19338064
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the microenvironment and adhesion of cancer cells by ADAMs (a disintegrin and metalloproteinase).
Okada Y
Verh Dtsch Ges Pathol; 2007; 91():29-38. PubMed ID: 18314593
[TBL] [Abstract][Full Text] [Related]
15. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
Xue A; Xue M; Jackson C; Smith RC
Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-driven selection of the metastatic phenotype.
Sullivan R; Graham CH
Cancer Metastasis Rev; 2007 Jun; 26(2):319-31. PubMed ID: 17458507
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-1, adipose tissue and insulin resistance.
Alessi MC; Poggi M; Juhan-Vague I
Curr Opin Lipidol; 2007 Jun; 18(3):240-5. PubMed ID: 17495595
[TBL] [Abstract][Full Text] [Related]
18. Protein C and its inhibitor in malignancy.
Suzuki K; Hayashi T
Semin Thromb Hemost; 2007 Oct; 33(7):667-72. PubMed ID: 18000793
[TBL] [Abstract][Full Text] [Related]
19. A novel model to study the biological effects of red wine at the molecular level.
Canali R; Ambra R; Stelitano C; Mattivi F; Scaccini C; Virgili F
Br J Nutr; 2007 Jun; 97(6):1053-8. PubMed ID: 17391552
[TBL] [Abstract][Full Text] [Related]
20. Cellular automata as microscopic models of cell migration in heterogeneous environments.
Hatzikirou H; Deutsch A
Curr Top Dev Biol; 2008; 81():401-34. PubMed ID: 18023736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
